Perindopril: Difference between revisions
From Proteopedia
Jump to navigationJump to search
David Canner (talk | contribs) No edit summary |
David Canner (talk | contribs) No edit summary |
||
| Line 6: | Line 6: | ||
* Date of FDA Approval (Patent Expiration): 1993 (2009)<br /> | * Date of FDA Approval (Patent Expiration): 1993 (2009)<br /> | ||
* 2005 Sales: $1 Billion | * 2005 Sales: $1 Billion | ||
* | * Importance: One of the best selling [[Angiotensin-Converting Enzyme]] Inhibitors of all time. | ||
* The following is a list of Pharmacokinetic Parameters. See: [[Pharmaceutical Drugs]] for more information | * The following is a list of Pharmacokinetic Parameters. See: [[Pharmaceutical Drugs]] for more information | ||
===Mechanism of Action=== | ===Mechanism of Action=== | ||
